Can progressive site‐directed therapy prolong the efficacy of subsequent androgen receptor axis‐targeted drugs in oligometastatic castration‐resistant prostate cancer?. (2nd November 2020) - Yoshida, Soichiro; Takahara, Taro; Yokoyama, Minato; Matsuoka, Yoh; Yoshimura, Ryoichi; Fujii, Yasuhisa